Gordon Campbell | Parliament TV | Parliament Today | Video | Questions Of the Day | Search


Second phase of vaccine clinical trials begins

24 October 2002 Media Statement

Second phase of Group B meningococcal vaccine clinical trials begins

Health Minister Annette King and the University of Auckland are pleased to announce the start of the second phase of clinical trials of a vaccine to fight group B meningococcal disease.

Ms King said the start of the new phase of clinical trials signified a big step toward combating the killer disease.

Clinical Trial Principal Investigator, Auckland University Professor Diana Lennon, said she was delighted. “Every step we take in this process brings us closer to significantly reducing the impact group B meningococcal disease is having on New Zealanders, and particularly children under five years old.

“Almost every day a child is admitted to hospital somewhere in New Zealand and the chances are these children will suffer long-term problems even if they survive this disease,” she said.

Ms King said last year 26 people of the 650 who contracted the disease died.

“Up to 20 percent of the other 624 would have been left with serious disability. Still more would have been left with educational or behavioural difficulties. Meningococcal disease has raged war in New Zealand at epidemic levels for 11 years now, and could easily continue to kill dozens and leave hundreds disabled every year for the next decade if we didn’t develop a vaccine,” she said.

“This disease affects New Zealanders from all walks of life, but the rate is particularly high amongst Pacific and Maori communities.

“The Government has committed significant resources, up to $200 million, to putting a stop to this dreadful disease as part of its wider commitment to improving child health and the health status of all New Zealanders.

“Immunisation is a simple, safe and effective way of protecting children from disease. Through vaccination we have been able to eliminate such serious diseases such as polio and diphtheria, and we are hoping that through the Meningococal Vaccine Strategy, group B meningococcal disease will join the list of diseases that we can use vaccination to fight,” Ms King said.

Phase I of the clinical trials involved 75 healthy adult volunteers. The first part of phase II involves about 300 eight to twelve-year-old children in the south Auckland suburbs of Manurewa and Papakura. The vaccine is similar to one that has been administered in more than 40 million doses overseas with no recorded unexpected serious adverse reactions.

The Ministry of Health, which manages the Meningococcal Vaccine Strategy, has contracted Auckland University to run the clinical trials. Auckland University is also responsible for evaluating the programme, in terms of vaccine effectiveness and epidemic control.

The vaccine was developed and is being manufactured by the Californian-based Chiron Corporation, in association with the Norwegian Institute of Public Health.


For background information on the Meningococcal Vaccine Strategy or meningococcal disease visit

© Scoop Media

Parliament Headlines | Politics Headlines | Regional Headlines

Gordon Campbell: On The Peters/Ardern Triumph

There are a lot of good reasons to feel joyful about this outcome. It is what so many young voters – the best hope for the country’s future – wanted.

Far more important than the implications for the Economy Gods ( is the dollar up or down? ) last night’s outcome will also mean many, many vulnerable New Zealanders will have a better life over the next three years at least.

Yet the desire for change was in the majority, across the country..>>>More


Labour on its agreement |Peters: Post-Election Announcement Speech | Greenpeace “cautiously hopeful” about new Government | ACT - Madman on the loose | E tū ecstatic | Chamber welcomes the outcome | Greens on their joining Govt | EDS welcomes new govt | Immigrant groups worry | Feds ready to engage new coalition government | Labour Ministers of the Crown announced


Climate: Increasing Greenhouse Emissions Hit NZ

New Zealand is seeing impacts of excess greenhouse gas emissions in our climate and oceans, according to the latest national report from the Ministry for the Environment and Stats NZ about the state of the atmosphere and climate…More>>


Wellington.Scoop: Arrests At Blockade Of "Weapons Expo"

“We encourage people in Wellington to get down to the Westpac Stadium now for a day of awesome peace action. There will be plenty of food, music and activities to keep us sustained through the day.” More>>


Rorschach Restructuring: PSA Taking Inland Revenue To Court Over Psychometrics

The Public Service Association will be seeing Inland Revenue in Employment Court over its intention to psychometrically test employees reapplying for their roles at the department as part of its controversial Business Transformation restructuring plan. More>>


Nuclear Disarmament: Nobel Peace Prize 2017 Awarded To ICAN

Congratulations from iCAN Aotearoa New Zealand to international iCAN, the other iCAN national campaigns and partner organisations, and the countless organisations and individuals who have worked so hard for a nuclear weapons-free world since 1945. More>>


Expenses: Waikato DHB CEO Resigns

An independent inquiry has identified that Dr Murray had spent more than the agreed $25K allocated for relocation costs, and other unauthorized expenses involving potential financial breaches of the chief executive’s obligations. More>>


Wellington.Scoop: Sad About The Trolley Buses?

The Regional Council’s MetLink is today spending money to tell us that it really loves Wellington’s trolley buses, even though they’re all being taken off our roads by the end of this month. More>>


Post-Election: Preliminary Coalition Talks Begin

New Zealand First will hold post-election preliminary discussions in Wellington with the National Party tomorrow morning and the Labour Party tomorrow afternoon. More>>




Featured InfoPages

Opening the Election